Information Provided By: 
Fly News Breaks for September 11, 2017
EW, MDT
Sep 11, 2017 | 06:23 EDT
Citi analyst Amit Hazan removed Medtronic (MDT) as his best idea for 2017 in Medical Supplies & Technology. His best idea is now Sell-rated Edwards Lifesciences (EW). After analyzing his thesis, Hazan is more cautious on Medtronic's sales growth relative to guidance for the year. The analyst highlights management's "consistent" execution challenges and communication problems. He cut his price target for Medtronic to $97 from $104 and keeps a Buy rating on the shares.
News For MDT;EW From the Last 2 Days
There are no results for your query MDT;EW
